Recon: AstraZeneca lines up EU accelerated assessment for COVID prevention drug; India expert panel urges local approval of Lilly’s Mounjaro
ReconJason Scott
Approval/marketing authorizationBiotechnologyEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited States